Bristol Myers Squibb Co. (BMY)
61.48
-1.52
(-2.41%)
USD |
NYSE |
Oct 23, 16:00
61.49
+0.01
(+0.02%)
Pre-Market: 20:00
Bristol Myers Squibb Price to Book Value : 5.628 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.628 |
| October 22, 2026 | 5.767 |
| October 21, 2026 | 5.595 |
| October 20, 2026 | 5.646 |
| October 19, 2026 | 5.385 |
| October 16, 2026 | 5.469 |
| October 15, 2026 | 5.544 |
| October 14, 2026 | 5.426 |
| October 13, 2026 | 5.187 |
| October 12, 2026 | 5.271 |
| October 09, 2026 | 5.412 |
| October 08, 2026 | 5.454 |
| October 07, 2026 | 5.465 |
| October 06, 2026 | 5.455 |
| October 05, 2026 | 5.383 |
| October 02, 2026 | 5.597 |
| October 01, 2026 | 5.626 |
| September 30, 2026 | 5.712 |
| September 29, 2026 | 5.754 |
| September 28, 2026 | 5.847 |
| September 25, 2026 | 5.754 |
| September 24, 2026 | 5.630 |
| September 23, 2026 | 5.597 |
| September 22, 2026 | 5.698 |
| September 21, 2026 | 5.732 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.772 |
| September 17, 2026 | 5.752 |
| September 16, 2026 | 5.822 |
| September 15, 2026 | 5.834 |
| September 14, 2026 | 5.868 |
| September 11, 2026 | 5.825 |
| September 10, 2026 | 5.835 |
| September 09, 2026 | 5.896 |
| September 08, 2026 | 5.922 |
| September 04, 2026 | 6.116 |
| September 03, 2026 | 6.233 |
| September 02, 2026 | 6.193 |
| September 01, 2026 | 6.126 |
| August 31, 2026 | 6.116 |
| August 28, 2026 | 6.094 |
| August 27, 2026 | 6.128 |
| August 26, 2026 | 6.185 |
| August 25, 2026 | 6.217 |
| August 24, 2026 | 6.159 |
| August 21, 2026 | 6.134 |
| August 20, 2026 | 5.993 |
| August 19, 2026 | 6.189 |
| August 18, 2026 | 6.046 |
| August 17, 2026 | 5.916 |
| August 14, 2026 | 5.843 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
| Merck & Co., Inc. | 8.552 |
| Pfizer Inc. | 2.009 |
| AstraZeneca PLC | 11.24 |
Price to Book Value Related Metrics
| PE Ratio | 13.54 |
| PS Ratio | 2.554 |
| PEG Ratio | 0.1629 |
| Price to Free Cash Flow | 10.98 |
| Price | 61.48 |
| Earnings Yield | 7.38% |
| Market Cap | 125.60B |
| PEGY Ratio | 0.1552 |
| Operating PE Ratio | 7.894 |
| Normalized PE Ratio | 10.01 |